Equities

USANA Health Sciences Inc

USANA Health Sciences Inc

Actions
  • Price (EUR)35.00
  • Today's Change-0.600 / -1.69%
  • Shares traded0.00
  • 1 Year change-36.94%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 30 2023202320222021
ASSETS
Cash And Short Term Investments330288240
Total Receivables, Net8.38109.43
Total Inventory616798
Prepaid expenses111114
Other current assets, total6.107.123.68
Total current assets418384365
Property, plant & equipment, net117118126
Goodwill, net171718
Intangibles, net303230
Long term investments20----
Note receivable - long term------
Other long term assets143534
Total assets633597578
LIABILITIES
Accounts payable101114
Accrued expenses333551
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.79----
Other current liabilities, total759797
Total current liabilities119144161
Total long term debt000
Total debt0.7900
Deferred income tax4.554.077.50
Minority interest------
Other liabilities, total121414
Total liabilities136162183
SHAREHOLDERS EQUITY
Common stock0.020.020.02
Additional paid-in capital665650
Retained earnings (accumulated deficit)445392345
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(14)(13)0.46
Total equity497434395
Total liabilities & shareholders' equity633597578
Total common shares outstanding191919
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.